U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H26ClNO4S
Molecular Weight 471.9982
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SB-773812

SMILES

CN1CCc2cc(c(cc2CC1)S(=O)(=O)c3ccc(cc3)OCc4ccc(cc4)Cl)OC

InChI

InChIKey=HIBWHHQXUSKNOV-UHFFFAOYSA-N
InChI=1S/C25H26ClNO4S/c1-27-13-11-19-15-24(30-2)25(16-20(19)12-14-27)32(28,29)23-9-7-22(8-10-23)31-17-18-3-5-21(26)6-4-18/h3-10,15-16H,11-14,17H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C25H26ClNO4S
Molecular Weight 471.9982
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Jun 26 11:58:57 UTC 2021
Edited
by admin
on Sat Jun 26 11:58:57 UTC 2021
Record UNII
ZNP5SNF9FY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SB-773812
Code English
1H-3-BENZAZEPINE, 7-((4-((4-CHLOROPHENYL)METHOXY)PHENYL)SULFONYL)-2,3,4,5-TETRAHYDRO-8-METHOXY-3-METHYL-
Systematic Name English
SB-737050-A
Code English
Code System Code Type Description
CAS
630407-66-8
Created by admin on Sat Jun 26 11:58:57 UTC 2021 , Edited by admin on Sat Jun 26 11:58:57 UTC 2021
PRIMARY
PUBCHEM
11467403
Created by admin on Sat Jun 26 11:58:57 UTC 2021 , Edited by admin on Sat Jun 26 11:58:57 UTC 2021
PRIMARY
FDA UNII
ZNP5SNF9FY
Created by admin on Sat Jun 26 11:58:57 UTC 2021 , Edited by admin on Sat Jun 26 11:58:57 UTC 2021
PRIMARY
CAS
1111896-95-7
Created by admin on Sat Jun 26 11:58:57 UTC 2021 , Edited by admin on Sat Jun 26 11:58:57 UTC 2021
NO STRUCTURE GIVEN
Related Record Type Details
TARGET -> INHIBITOR
IN-VIVO HUMAN HUMAN OCCUPANCY LEVEL; 30% D2 occupancy at Tmax, maintained at trough
ANTAGONIST
EC50
TARGET -> INHIBITOR
IN-VIVO HUMAN HUMAN OCCUPANCY LEVEL; . 5-HT2A occupancy ranged from 91% to 100% when dosed at 56 mg
ANTAGONIST
EC50
TARGET -> INHIBITOR
ANTAGONIST
Ki
TARGET -> INHIBITOR
ANTAGONIST
Ki
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
ANTAGONIST
Ki
TARGET -> INHIBITOR
ANTAGONIST
Ki
TARGET -> INHIBITOR
ANTAGONIST
Ki
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
ACTIVE MOIETY